Analytical Data
-
基因名
Lithostathine-1/Reg1
-
简介
Lithostathine-1/Reg1 Protein potentially inhibits spontaneous calcium carbonate precipitation.Lithostathine-1/Reg1 Protein, Mouse (His-SUMO) is the recombinant mouse-derived Lithostathine-1/Reg1 protein, expressed by E.coli , with N-His, N-SUMO labeled tag.
- Application
-
别名
Reg1; Lithostathine-1; Islet of Langerhans regenerating protein 1; REG 1; Pancreatic stone protein 1; PSP; Pancreatic thread protein 1; PTP; Regenerating protein 1
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His;N-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P43137
-
表达区间
Q22-G165
-
蛋白长度
Full Length of Mature Protein
-
分子量
32 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Lithostathine-1, also known as Reg1, is a prominent member of the regenerating protein family, primarily found in the pancreas and involved in various physiological processes, including cell growth, differentiation, and regeneration. It plays a critical role in the modulation of inflammation and tissue repair, making it a subject of interest in various biomedical research areas, particularly concerning diabetes and pancreatitis. The expression of lithostathine-1/Reg1 is often upregulated in pancreatic diseases, suggesting its potential as a biomarker and therapeutic target. Research on the recombinant form of this protein has gained traction, as it allows for in-depth studies of its biological functions, structural properties, and interactions with other cellular components. By utilizing recombinant DNA technology, scientists can produce significant quantities of lithostathine-1 for analytical and experimental applications, aiding in the elucidation of its mechanisms of action. Furthermore, the recombinant protein can be employed in drug delivery systems or as a biomarker for early diagnosis, thus holding promise for advancing therapeutic strategies against pancreatic disorders. Given the increasing prevalence of pancreatic diseases globally, the exploration of lithostathine-1/Reg1 through recombinant protein studies can offer insights into new treatment modalities and improve understanding of pancreatic pathology.
